OUR PRODUCTS

MOBILE APPS

GENERAL INFO

RLYB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Rallybio (RLYB) Earnings Date & Reports

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RLYB is expected to report earnings to fall 11.36% to -19 cents per share on November 06

Q3'25

Est.

$-0.19

Q2'25

Beat

by $0.02

Q1'25

Beat

by $0.07

Q4'24

Beat

by $0.55

Q3'24

Beat

by $0.09

The last earnings report on August 07 showed earnings per share of -21 cents, beating the estimate of -23 cents. With 225.00K shares outstanding, the current market capitalization sits at 24.64M.

View a ticker or compare two or three

Compare

RLYB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RLYB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RLYB showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

234 Church Street

Phone

+1 203 859-3820

Employees

Web

https://www.rallybio.com